Pharmacies in England will be able to prescribe medicines for seven common conditions without a GP prescription under new proposals intended to relieve the pressure on pri
The World Health Organization (WHO) has said that COVID-19 is no longer a public health emergency of international concern (PHEIC), more than three years after it first de
Headlines about the results of TRAILBLAZER-ALZ2 trial of Eli Lilly’s Alzheimer’s drug candidate donanemab are spreading around the world, with some going as far as to sugg
Akili Interactive has revealed the findings of a trial of its digital therapeutic (DTx) for attention-deficit hyperactivity disorder (ADHD) in adults, suggesting it may be
The FDA has issued draft guidance on the use of decentralised clinical trials (DCTs), which are increasingly being used by the pharma industry to tackle issues, such as di